TRVI
Trevi Therapeutics
$12.51
−$0.10 (−0.79%)Oct 26, 2026
Key metrics
The numbers that frame TRVI today
- Market cap
- $1.78B
- ROIC
- -28.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $9.82
- 52wk High
- $20.15
Growth
Revenue and earnings trend for TRVI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TRVI
Is Trevi Therapeutics a good buy?
Hold. Trevi Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Trevi Therapeutics is selling at a high price.
What is the market capitalization of TRVI?
Trevi Therapeutics's market capitalization is $1.78B.
What is the 52-week high for TRVI stock?
The 52-week high for Trevi Therapeutics is $20.15. The current close of $12.51 is 37.9% below that high.
What is the 52-week low for TRVI stock?
The 52-week low for Trevi Therapeutics is $9.82. The current close of $12.51 is 27.4% above that low.
Does TRVI stock pay dividends?
Trevi Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TRVI?
Trevi Therapeutics's Debt / Equity ratio is 0.